2016 Fiscal Year Final Research Report
A development of novel molecular target therapy targeting IL-17 for peritoneal metastasis of gastrointestinal cancer
| Project/Area Number |
26861099
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Digestive surgery
|
|---|
| Research Institution | Wakayama Medical University |
|---|
Principal Investigator |
Hayata keiji 和歌山県立医科大学, 医学部, 学内助教 (90637654)
|
|---|
| Project Period (FY) |
2014-04-01 – 2017-03-31
|
| Keywords | IL-17 / 腫瘍免疫 / 血管新生 / がん幹細胞 / 腹膜転移 / 消化器癌 |
|---|
| Outline of Final Research Achievements |
The inhibiting IL-17 in the peritoneal metastasis model of gastrointestinal cancer in mice releases the tumor immunity escape mechanism of Treg cells and MDSC, produces a Th1 dominant immune environment, and augments anti-tumor immunity. Furthermore, the inhibition of IL-17 suppressed angiogenesis, however, it could not reduce cancer stem cells. IL-17 is one of new molecular targets in peritoneal metastasis of gastrointestinal cancer.
|
| Free Research Field |
消化器外科
|
